Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Expression of Rap1GAP in human myeloid disease following microarray selection.

Authors: Qi, X  Chen, Z  Qian, J  Cen, J  Gu, M 
Citation: Qi X, etal., Genet Mol Res. 2008 Apr 29;7(2):379-87.
Pubmed: (View Article at PubMed) PMID:18551404

To find the underlying causes of primary myelodysplastic syndrome (MDS), the gene expression profiling of both CD34+ cells and bone marrow mononuclear cells from MDS patients was performed using oligonucleotide microarray and cDNA microarrays, respectively. Several candidate genes which were differentially expressed in MDS patients versus normal controls were selected and confirmed in expanding samples by quantitative real-time reverse transcription-polymerase chain reaction after clustering and bioinformatics analysis. one of these genes, RAP1GAP, was found to be expressed at a significantly higher level in patients with MDS in comparison with those suffering from other hematopoietic diseases including leukemia (P < 0.01). We propose that over-expression of RAP1GAP gene may play a role in the pathogenesis of MDS.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 9835346
Created: 2015-03-18
Species: All species
Last Modified: 2015-03-18
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.